Abstract：Objective: To study the effect of dexmedetomidine on analgesia and intestinal function after radical resection of colon cancer. Methods: 80 patients with colon cancer underwent radical operation in our hospital from March 2017 to March 2018 were selected. According to simple random number table, the patients were divided into observation group (45 cases) and control group (35 cases). According to simple random number table,those patients were divided into the observation group (n=45) and the control group (n=38). The control group was injected with normal saline before induction of general anesthesia, while the observation group was injected with dexmedetomidine. Then the surgical recovery index (recovery time, first exhaust time, recovery time of spontaneous breathing, time of eating common food, recovery time of bowel sounds), Visual Analogue Scale/Score at 1 hour, 3 hours, 6 hours, 12 hours, 24 hours after operation, Systolic pressure, diastolic blood pressure, mean artery pressure levels before operation, immediately after intubation, immediately after extubation, immediately after extubation, incidence of adverse reactions of two groups before and after treatment were compared. Results: The Recovery time, first exhaust time, recovery time of spontaneous breathing, common food intake time, recovery time of bowel sounds in the observation group were significantly lower than those in the control group(P＜0.05). Postoperative 1H, postoperative 3h, postoperative 6h, postoperative 12h and postoperative 24hVAS scores were significantly lower than those of the control group(P＜0.05).Preoperative, intubation, immediate and immediate extubation of SBP, DBP and MAP were significantly lower than those of the control group(P＜0.05).The total incidence of adverse reactions was significantly lower than that of the control group[15.55%(7/45)vs34.21％(13/38)](P＜0.05). Conclusion: . Dexmedetomidine has remarkable analgesic effect after radical resection of colon cancer. It can improve analgesic and sedative effect, reduce fluctuation of vital signs, promote faster recovery of gastrointestinal function and reduce adverse reactions.
安彬, 刘硕, 陶德强. 右美托咪啶对结肠癌根治术的镇痛效果及术后肠功能的影响[J]. 河北医学, 2019, 25(8): 1390-1393.
AN Bin, LIU Shuo, TAO Deqiang. Effect of Dexmedetomidine on Analgesia and Intestinal Function after Radical Resection of Colon Cancer. HeBei Med, 2019, 25(8): 1390-1393.
[1] 邢宝成,李晓华,赵辉,等.右美托咪定辅助舒芬太尼用于结肠癌术后静脉镇痛对SIRS评分影响[J].中国老年学杂志,2015,35(11):3133~3134. [2] Huang L, Zhang S, Zhou J, et al. Effect of resveratrol on drug resistance in colon cancer chemotherapy[J]. RSC Advances, 2019, 9(5):2572~2580. [3] 周斌,肖凡,陈勇,等.围术期应用右美托咪定对结肠癌根治术后肠麻痹的影响[J].临床麻醉学杂志,2016,32(04):328~332. [4] 陈裕强.右美托咪定联合舒芬太尼应用于结肠癌术后的镇痛效果[J].检验医学与临床,2016,13(08):1057~1059. [5] 康清杰,向征.结肠癌筛查和诊疗的研究进展[J].重庆医学,2015,44(28):4001~4003. [6] 李爱国,陈治军,蒋奕红,等.右美托咪定复合罗哌卡因在结肠癌术后镇痛的应用及其对患者免疫功能的影响[J].肿瘤药学,2018,8(02):179~183. [7] Jurowich C, Lichthardt S, Matthes N, et al. Comparison of conventional access routes for right hemicolectomy in colon cancer-data from the DGAV StuDoQ registry[J]. International Journal of Colorectal Disease, 2019, 34(1):161~167. [8] 唐珩,张培俊,李艳华,等.利多卡因联合帕瑞昔布在老年人腹腔镜结肠癌根治术中的应用[J].世界华人消化杂志,2014,22(14):2059~2063.
2019, Vol. 25 
冀公网安备13080202000677号